VolitionRx Ltd (VNRX) stock
VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.19−0.01 (-5.56%)
Close on Nov 17, 2026Market cap $2.58MP/E –Yield –
VolitionRx price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
VolitionRx's price to sales ratio was 1.0× on Nov 11, 2026, against 24.0× a year earlier. Over the last 4 years it ranged from 1.0× to 496.0×, with a median of 58.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.0× | −18.0 |
| 2025 | Dec 31, 2025 | 19.0× | −24.1 |
| 2024 | Dec 31, 2024 | 43.1× | −43.5 |
| 2023 | Dec 29, 2023 | 86.6× | −291.5 |
| 2022 | Sep 30, 2022 | 378.1× | −113.2 |
| 2013 | Apr 30, 2013 | 491.3× | −4.7 |
| 2012 | Dec 31, 2012 | 496.0× | – |
See a number that looks wrong?